Variantyx

We See More In Every Genetic Test

Boston, United States · Founded 2014 · $100.0M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$100.0M
Last Round
$36.0M Series DApr 2024
Rounds
6

About

Variantyx is a molecular diagnostics company offering whole-genome-based genetic testing for rare genetic disorders, neurology, reproductive genetics, and precision oncology. Its Genomic Unity platform delivers comprehensive variant detection using both short-read and Oxford Nanopore long-read whole genome sequencing, serving clinicians and healthcare providers.

Summary

Variantyx is a Diagnostics company based in Boston, United States, founded in 2014. It has raised $100.0M in total across 6 rounds, most recently a $36.0M Series D round in Apr 2024. Investors include Kreos Capital, GHS Fund and New Era Capital Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DApr 2024
$36.0M

Sign up to see all 7 rounds

Seed through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Variantyx on Indexed.vc
<a href="https://indexed.vc/companies/variantyx"><img src="https://indexed.vc/api/badge/company/variantyx" alt="Variantyx on Indexed.vc" width="260" height="76" /></a>